Could Dynamic Duo Diageo plc And GlaxoSmithKline plc Make You A Millionaire?

GlaxoSmithKline plc (LON: GSK) and Diageo plc (LON: DGE) are the perfect shares to get rich slowly.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The £1m mark is a key goal for many investors and the most effective way to hit this target is slowly, without taking excessive risks. Personally, I think the best investments to help you do this are GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE). 

Glaxo and Diageo won’t run you into Warren Buffett overnight, but they will help you meet your savings goals. Indeed, his first rule of investing is “don’t lose money”, the second rule is “don’t forget rule one”. Losing money can be extremely damaging to you investment returns and even a small 10% loss can hold you back for years.

And neither Glaxo nor Diageo will cost you money. Their shares may fall in the short term but over the long term they should push steadily higher.

Defensive companies

You see, Diageo and Glaxo are defensive companies. Diageo is the world’s largest alcoholic beverage company, with some of the world’s bestselling spirit brands in its drinks cabinet. Meanwhile, Glaxo is a leading pharmaceutical company, which manufactures a broad selection of every day treatments and consumer goods that have become consumer staples over the years.

So, Diageo and Glaxo are not going to go out of business any time and it’s highly unlikely that either company will see its share price go to zero. 

With this being the case, investors can buy and hold the two companies’ shares in their portfolios over the long term without much worry. What’s more, both Glaxo and Diageo have a history of returning the majority of their earnings to investors in the form of dividends. Through the power of compounding, these cash returns have helped accelerate total returns achieved from the investments.

The power of compounding

If you invested £1,000 in Diageo during 1995, with dividends invested that stake would be worth £5,200 today, an average annual return of 10.10%. Similarly, if you’d purchased £1,000 of Glaxo stock during 1995, that stake would be worth £4,412 today, after achieving an average annual return of 7.9%. 

These figures may not seem like much at first glance, but for the long-term investor the returns really start to add up. Over four decades, a £1,000 investment in Glaxo, made during 1995 will be worth around £23,000 by 2035. However, the Diageo investment would worth a staggering £55,000 by 2035.

If you were to invest £1,000 in each company and add an additional £1,000 to each holding every year, based on the above rate of growth, your portfolio would be worth just under £1m by 2035.

Based on these numbers then, Glaxo and Diageo could make you a millionaire. 

Glaxo currently trades at a forward P/E of 17.3, which seems expensive but the company trades at a discount of about 10% to its international peers. The company’s shares offer a yield of 4.9%. Diageo currently trades at a forward P/E of 20.4, in line with its international peers and the company offers a dividend yield of 2.6%. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

£5,000 invested in B&M shares at the start of 2026 is now worth…

After years of catastrophic decline, B&M shares are starting to bounce back, firmly beating the stock market in 2026 so…

Read more »

Aviva logo on glass meeting room door
Investing Articles

Aviva shares now yield 6.6%. Time to consider buying?

The dividend yield on Aviva shares is currently at a very attractive level. Could the insurer be a great source…

Read more »

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

Investing £500 a month in FTSE shares for 10 years unlocks a passive income of…

Zaven Boyrazian breaks down the strategies investors can use to unlock almost £16,000 of passive income using FTSE shares and…

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

No savings at 40? Filling an empty ISA with cheap shares could help you retire earlier

The right cheap shares can turbocharge a portfolio for the years to come and even help investors unlock an earlier…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Experts say these are the 7 best UK shares to buy right now!

This team of analysts has highlighted seven stocks in the UK industrials sector that could be perfectly positioned to deliver…

Read more »

4 Teslas in a parking lot at a charger station
Investing Articles

£1,000 invested in Tesla stock 5 years ago is now worth…

Tesla stock is up 69% in the last five years, but its earnings per share are down. Stephen Wright outlines…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

At a price of 3.2p, could this penny share deliver huge portfolio gains?

Forecasts project this penny share could surge as much as 186% in the next 12 months! Is this too good…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Here are the best-performing S&P 500 stocks in 2026 so far

Zaven Boyrazian explores the best-performing S&P 500 stocks of 2026 so far, with one recently minted business already more than…

Read more »